ReviewAdvances in experimental medicine and biology2025
Iron and Liver Disease.
Review in Advances in experimental medicine and biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Impact of transfusion-associated iron overload on hepatic and renal function in patients with aplastic anemia: a retrospective cohort study of 145 cases.American journal of translational research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The mutual relationship between iron and liver disease is highlighted by the fact that too much iron can cause liver disease, while hepatic iron overload can also result from acute or chronic liver diseases. As the principal storage site for iron, hepatic iron concentration is a reliable surrogate marker for total body iron in iron overload conditions. Assessment of hepatic iron is therefore important for the initiation and monitoring of treatment of iron overload by therapeutic phlebotomies or iron chelators. The present chapter reviews how the liver controls iron homeostasis, and discusses how liver iron can be assessed before primary and secondary liver diseases with iron overload.
Indexed as
Identifiers
40603795What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.